SEC Form 4 · accession 0001209191-17-063617
G1 Therapeutics, Inc. · GTHX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christy L Shaffer
Director
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 30, 2017 | J | 99,513 | $0.00 | D | 0 | I | By L2 Ventures, LLC |
| Common StockF3,F4 | Nov 30, 2017 | J | 995 | $0.00 | A | 995 | I | By Hatteras Venture Advisors V, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In-kind distribution from L2 Ventures, LLC to its members, without consideration.
- F2The Reporting Person is one of the general partners of Hatteras Venture Advisors V, LLC, which is the general partner of L2 Ventures, LLC ("L2 Ventures"). L2 Ventures is the record holder of the securities, and the Reporting Person may be deemed to share voting and dispositive power over the securities held by L2 Ventures. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.
- F3In-kind distribution from L2 Ventures, LLC to its members, including Hatteras Venture Advisors V, LLC, without consideration.
- F4The Reporting Person is one of the general partners of Hatteras Venture Advisors V, LLC, which is the record holder of the securities, and the Reporting Person may be deemed to share voting and dispositive power over the securities held by Hatteras Venture Advisors V, LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.